Study of Oglemilast for the Prevention of Asthma.

Completed · Phase 2 · Has a placebo group

Conditions studied: Exercise-Induced Asthma

In brief

The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.

Key facts

Study ID

NCT00322283

Run by

Forest Laboratories

People needed

24

Starts

2006-05-01

Expected to finish

2006-10-01

Last updated by the study team

2012-04-10

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• stable mild asthma patients who exhibit at least a 20% decrease in FEV1 following exercise.

You may not qualify if…

• pulmonary disease other than asthma, psychiatric illness, active cardiac disease, high blood pressure, history of substance abuse, current smokers.

Where it is running

• Forest Investigative Site — Los Angeles, California, United States
• Forest Investigative Site — North Dartmouth, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.